![]() |
HIV Infection |
Free Subscription
3 AIDS |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO HIV Infection is free of charge.
Effect of a climate-smart intervention on agriculture and nutrition of people
with HIV: a cluster-randomized trial.
AIDS. 2025 May 15. doi: 10.1097/QAD.0000000000004234.
PubMed
Abstract available
Reducing HIV incidence in the southern US through routine opt-out HIV screening.
AIDS. 2025 May 15. doi: 10.1097/QAD.0000000000004237.
PubMed
Abstract available
Adverse childhood experiences, sexual orientation-related victimization, and
cardiovascular disease risk among men living with and without HIV.
AIDS. 2025 May 15. doi: 10.1097/QAD.0000000000004235.
PubMed
Abstract available
Identification of Two Novel HIV-1 Unique Recombinant Forms Among Men Who Have Sex
with Men in Northern China.
AIDS Res Hum Retroviruses. 2025 May 15. doi: 10.1089/aid.2024.0131.
PubMed
Abstract available
Histoplasma antigenuria prevalence in patients with advanced HIV disease in Cote
d'Ivoire: a prospective trial ancillary study.
Clin Infect Dis. 2025 May 16:ciaf237. doi: 10.1093.
PubMed
Abstract available
Risk of cancer in people with HIV experiencing varying degrees of immune recovery
with sustained virological suppression on antiretroviral treatment for more than
2 years: an international, multicentre, observational cohort.
Clin Infect Dis. 2025 May 15:ciaf248. doi: 10.1093.
PubMed
Abstract available
Histoplasma antigen screening in advanced HIV disease.
Clin Infect Dis. 2025 May 13:ciaf238. doi: 10.1093.
PubMed
Immunogenicity and safety of two versus three doses of 9-valent vaccine against
Human papillomavirus (HPV) in women with HIV: the Papillon randomized trial.
Clin Infect Dis. 2025 May 13:ciaf241. doi: 10.1093.
PubMed
Abstract available
HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record Based
Cohort Study.
Clin Infect Dis. 2025 May 12:ciaf242. doi: 10.1093.
PubMed
Abstract available
Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant
Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
Clin Infect Dis. 2025 May 9:ciaf112. doi: 10.1093.
PubMed
Abstract available
Treatment of Advanced HIV in the Modern Era.
Drugs. 2025 May 12. doi: 10.1007/s40265-025-02181.
PubMed
Abstract available
Dual cross-sectional and longitudinal perspective on the continuum of HIV care to
disentangle natural epidemic evolution from real progress, Belgium 2014-2022.
HIV Med. 2025 May 12. doi: 10.1111/hiv.70027.
PubMed
Abstract available
Impact of Depression at HIV PrEP Initiation on Sustained PrEP Care Engagement
Among US Gay and Bisexual Men.
J Acquir Immune Defic Syndr. 2025 May 15. doi: 10.1097/QAI.0000000000003698.
PubMed
Abstract available
Out-of-pocket costs for PrEP ancillary services among U.S. commercially insured
persons, 2017-2022.
J Acquir Immune Defic Syndr. 2025 May 14. doi: 10.1097/QAI.0000000000003695.
PubMed
Abstract available
Association between changes in script renewal periods and HIV viral
non-suppression: a cohort study of a South African private-sector HIV program.
J Acquir Immune Defic Syndr. 2025 May 14. doi: 10.1097/QAI.0000000000003697.
PubMed
Abstract available
Investigation of Integrase Inhibitor Resistance Mutations in gp41 in Clinical
Samples.
J Acquir Immune Defic Syndr. 2025 May 13. doi: 10.1097/QAI.0000000000003694.
PubMed
Abstract available
Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support
Multidosing: PETITE-Dolutegravir Study.
J Acquir Immune Defic Syndr. 2025;99:195-201.
PubMed
Abstract available
Reevaluating the clinical relevance of bacterial vaginosis-associated immune
responses in HIV infection.
J Infect Dis. 2025 May 14:jiaf227. doi: 10.1093.
PubMed
Gastrointestinal Dysmotility, Autonomic Function and Small Intestinal Bacterial
Overgrowth among People with Well-Controlled HIV.
J Infect Dis. 2025 May 13:jiaf238. doi: 10.1093.
PubMed
Abstract available
Clicking viruses-with chemistry toward mechanisms in infection.
J Virol. 2025 May 14:e0047125. doi: 10.1128/jvi.00471.
PubMed
Abstract available
Distinct region-specific neutralization profiles of contemporary HIV-1 clade C
against best-in-class broadly neutralizing antibodies.
J Virol. 2025 May 16:e0000825. doi: 10.1128/jvi.00008.
PubMed
Abstract available
One Million New Pediatric HIV Cases Predicted If PEPFAR Funding Is Cut.
JAMA. 2025 May 9. doi: 10.1001/jama.2025.6155.
PubMed
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa.
N Engl J Med. 2025;392:1917-1932.
PubMed
Abstract available
Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries.
N Engl J Med. 2025 May 14. doi: 10.1056/NEJMsa2414435.
PubMed
Abstract available
Editorial Note: Metabarcoding analysis of eukaryotic microbiota in the gut of
HIV-infected patients.
PLoS One. 2025;20:e0324348.
PubMed
The effect of location in mining or borderland areas on HIV incidence among
people who use drugs attending a harm reduction programme in Myanmar, 2014-2021:
A retrospective cohort study.
PLoS One. 2025;20:e0295727.
PubMed
Abstract available
Sheltering from the storm: The role of a quality improvement collaborative
focused on improving HIV care retention in New Orleans during and following
Hurricane Ida.
PLoS One. 2025;20:e0323026.
PubMed
Abstract available
Resistance to tuberculin skin test/interferon-gamma release assay conversion
among highly TB exposed, HIV infected goldminers in South Africa.
PLoS One. 2025;20:e0318819.
PubMed
Abstract available
'I was like, this is gonna hurt': Implementing self-sampling of dried blood spots
to measure HIV viral load.
PLoS One. 2025;20:e0322740.
PubMed
Abstract available
Treatment outcomes among young persons living with HIV who transitioned to adult
care in southern Nigeria: A retrospective cohort study.
PLoS One. 2025;20:e0321962.
PubMed
Abstract available
The effect of the universal test and treat strategy on the kidney function in
adults living with HIV in Zambia: A six-month multicenter cohort study.
PLoS One. 2025;20:e0323618.
PubMed
Abstract available
Development and calibration of a mathematical model of HIV outcomes among Rwandan
adults: Informing achievement of global targets across sub-populations in Rwanda.
PLoS One. 2025;20:e0310662.
PubMed
Abstract available
Ensuring equitable access to quality HIV care for affected populations in complex
sociocultural settings: Lessons from Nigeria.
PLoS One. 2025;20:e0319807.
PubMed
Abstract available
Quality of life and retention in care among people living with HIV initiated on
ART in the era of "Universal Test and Treat" policy at a large HIV Clinic in
South Western Uganda.
PLoS One. 2025;20:e0324024.
PubMed
Abstract available
Rev-RRE activity modulates HIV-1 replication and latency reactivation:
Implications for viral persistence and cure strategies.
PLoS Pathog. 2025;21:e1012885.
PubMed
Abstract available
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb
precursors in humans.
Science. 2025 May 15:eadr8382. doi: 10.1126/science.adr8382.
PubMed
Abstract available
Precise targeting of HIV broadly neutralizing antibody precursors in humans.
Science. 2025 May 15:eadv5572. doi: 10.1126/science.adv5572.
PubMed
Abstract available
Factors associated with laboratory-confirmed SARS-Cov-2 infection among patients
with severe respiratory illness (SRI): Findings from the COVID-19 vaccine
effectiveness evaluation in Kenya and Mali, 2022-2023.
Vaccine. 2025 May 12:127234. doi: 10.1016/j.vaccine.2025.127234.
PubMed
Abstract available
Thank you for your interest in scientific medicine.